about
Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin α1-antitrypsin ZEmerging techniques for the discovery and validation of therapeutic targets for skeletal diseases.Development of a generic dual-reporter gene assay for screening G-protein-coupled receptors.Multiplexing Fluo-4 NW and a GeneBLAzer transcriptional assay for high-throughput screening of G-protein-coupled receptors.Natural products that reduce rotavirus infectivity identified by a cell-based moderate-throughput screening assayDevelopment of a homogeneous calcium mobilization assay for high throughput screening of mas-related gene receptor agonists.An improved beta-lactamase reporter assay: multiplexing with a cytotoxicity readout for enhanced accuracy of hit identification.Apparent activity in high-throughput screening: origins of compound-dependent assay interferenceIdentifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.Approaches in fostering quality parameters for medicinal botanicals in the Indian contextQuantification of the effects of ionic strength, viscosity, and hydrophobicity on protein-ligand binding affinity.Microarray-based fluorescence assay of endonuclease functionality and inhibition.1Click1View: interactive visualization methodology for RNAi cell-based microscopic screening.Flow cytometry enables a high-throughput homogeneous fluorescent antibody-binding assay for cytotoxic T cell lytic granule exocytosis.A cell-based screening system for influenza A viral RNA transcription/replication inhibitorsUsing Caenorhabditis elegans to study serpinopathies.Progress in methodology. Improved reporter gene assays used to identify ligands acting on orphan seven-transmembrane receptors.A cell-based PDE4 assay in 1536-well plate format for high-throughput screening.Optimization of fluorescence assay of cellular manganese status for high throughput screeningCurrent Screens Based on the AlphaScreen Technology for Deciphering Cell Signalling PathwaysDevelopment of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents.A Multiplexed Fluorescent Calcium and NFAT Reporter Gene Assay to Identify GPCR Agonists.Redox cycling compounds generate H2O2 in HTS buffers containing strong reducing reagents--real hits or promiscuous artifacts?Advances in flow cytometry for drug screening.Developing assays for kinase drug discovery - where have the advances come from?Microarray detection of duplex and triplex DNA binders with DNA-modified gold nanoparticles.A gold nanoparticle based approach for screening triplex DNA binders.Evaluation of cell-based assays for steroid nuclear receptors delivered by recombinant baculoviruses.Gene Promoters and Transcription Control Regions as Therapeutic Targets
P2860
Q21562132-8EB1D001-DDCF-479C-BD7A-43B2E6CE4DFEQ31120838-AB84C9AE-928D-4DEB-95EF-113FF17CECE8Q33221504-B2624530-2E8D-4D1A-B294-ABBB615E0141Q33249487-48EF7E99-C125-47E2-B39F-E53BF3FA45A3Q33256133-BBB295B3-8FC0-4B73-945F-6A78EB114761Q33267401-95012C74-9F69-4322-9064-7B1403037A43Q33285353-E5ABF4A0-850D-401C-B9B0-BA6FA0E6F4BAQ33563613-5F601418-993F-408D-BC85-BE8E17D13CB6Q33772474-43C39131-8B0B-4746-9588-6C57ABBBDD8BQ33987245-46FA2B95-DA81-4C47-9A26-81343929638DQ34063684-49FF5906-5BC3-4FFA-93F8-9D5C35EC0355Q34320524-6D6E67D4-03FC-4B8F-BBB5-B2F2B7AA721EQ34332561-906BB564-EE85-44B6-8B50-3A16D95955A2Q34480436-BBB1F596-9A47-4798-BB8D-BFC1DE780C22Q34560792-1CAFABB3-5DAE-4299-8768-C597FC707AD6Q35218752-D7D78A71-BBF3-42B2-9BC9-44EB3AED4DDDQ35607719-0BBEED21-C484-437C-82E7-FB58F91EF102Q37141161-95E1548E-AFDE-4D74-BB52-55F5A7150869Q37174262-05DF4081-8930-4158-8F2B-07736C0224EEQ37236182-1FCA9635-21F7-401C-B14D-6D421EEBA378Q37364643-91C82D75-3F4F-402F-B14E-7855AD6DA26AQ37372069-220C1840-9D46-47B6-8270-FF9AF4EC76D6Q37809299-4F638B2D-55F8-46AA-9B96-3E5E610F11BBQ38028568-064BB505-436A-4CEF-82B5-7203DCD66248Q38088287-A2264B73-F8E9-4FE0-A6C8-8171FE1B93E2Q38300263-45364AC4-D1C7-432A-855F-BCB533A9AD1CQ38314333-C8037B1A-CE59-4413-947D-069E44DFE9C9Q40380167-13BD1C7E-084E-4BE3-A32E-89D13C316290Q58035083-DD0AE1D2-6F34-4B31-A0B8-1D3C6478703A
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cellular platforms for HTS: three case studies.
@ast
Cellular platforms for HTS: three case studies.
@en
Cellular platforms for HTS: three case studies.
@nl
type
label
Cellular platforms for HTS: three case studies.
@ast
Cellular platforms for HTS: three case studies.
@en
Cellular platforms for HTS: three case studies.
@nl
prefLabel
Cellular platforms for HTS: three case studies.
@ast
Cellular platforms for HTS: three case studies.
@en
Cellular platforms for HTS: three case studies.
@nl
P1433
P1476
Cellular platforms for HTS: three case studies.
@en
P2093
Patricia A Johnston
Paul A Johnston
P304
P356
10.1016/S1359-6446(01)02140-7
P577
2002-03-01T00:00:00Z